CPIX insider trading
NasdaqGS HealthcareCUMBERLAND PHARMACEUTICALS INC: insider trade history from SEC Form 4 filings.
About CUMBERLAND PHARMACEUTICALS INC
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Company website: www.cumberlandpharma.com
CPIX insider activity at a glance
FilingIQ tracks 4,068 insider transactions for CPIX in filings since Mar 20, 2015. The most recent transaction is dated Mar 18, 2026.
Across the full history, 2,746 open-market purchases
and 87 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CPIX insider trades is 49.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CPIX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CPIX?
- FilingIQ tracks 4,068 Form 4 insider transactions for CPIX (CUMBERLAND PHARMACEUTICALS INC), covering filings from Mar 20, 2015 onwards. 0 of those are dated within the last 90 days.
- Are CPIX insiders net buyers or net sellers?
- Across the full Form 4 history for CPIX, 2,746 transactions (68%) were open-market purchases and 87 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CPIX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CPIX in?
- CUMBERLAND PHARMACEUTICALS INC (CPIX) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $58.27M.
Methodology & sources
Every CPIX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.